|
⚲
|
| Cingulate Inc | |
|---|---|
| Ticker | CINGW |
| CIK # | 0001862150 |
| CUSIP | 17248W113 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 1901 W 47th Place, Kansas City, KS 66205 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001862150] | 10-K | |
| [0001862150] | 10-Q | |
| [0001862150] | 3 | |
| [0001862150] | 4 | |
| [0001862150] | 8-K | |
| [0001862150] | D | |
| [0001862150] | SC 13D | |
| [0001862150] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Lind Global Fund II LP | Cingulate Inc | [2024-02-09] | 9.9 |
| Brams Matthew | Cingulate Inc | [2022-02-14] | 5.8 |
| Schaffer Shane J | Cingulate Inc | [2021-12-20] | 7.4 |
| Werth Peter J | Cingulate Inc | [2021-12-20] | 7.7 |
| Sabby Management LLC | Cingulate Inc | [2021-12-14] | 5.33 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Hudson Bay Capital Management LP | [2025-06-30] | SOLE | 210,798 | 210,798 |
| Goalvest Advisory LLC | [2025-06-30] | SOLE | 3,000 | 3,000 |
| Concourse Financial Group Securities Inc | [2025-06-30] | SOLE | 0 | 0 | Prev | Page 1007 | Next |